IGM Biosciences, Inc.·4

Mar 18, 7:07 PM ET

Decker Lisa Lynn 4

4 · IGM Biosciences, Inc. · Filed Mar 18, 2025

Insider Transaction Report

Form 4
Period: 2025-03-14
Decker Lisa Lynn
CHIEF BUSINESS OFFICER
Transactions
  • Sale

    Common Stock

    2025-03-14$1.23/sh4,512$5,55073,529 total
Footnotes (2)
  • [F1]These shares were sold to cover tax withholding obligations in connection with the vesting of restricted stock units.
  • [F2]This transaction was executed in multiple trades at prices ranging from $1.19 to $1.28. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer full information regarding the number of shares sold at each separate sale price.

Documents

1 file
  • 4
    form4-03182025_110359.xmlPrimary